Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3942683 | 1.00 | MEN1 (0.37) | MEN1KMT2AATMPABPC1EIF4H | |
| SCHEMBL3936234 | 0.97 | MEN1 (0.38) | MEN1KMT2AATMPABPC1EIF4H | |
| SCHEMBL3936236 | 0.97 | MEN1 (0.38) | MEN1KMT2AATMPABPC1EIF4H | |
| SCHEMBL3944176 | 0.92 | KDM4E (0.36) | MEN1KMT2APABPC1EIF4HCTDSP1 | |
| SCHEMBL3944179 | 0.92 | KDM4E (0.36) | MEN1KMT2APABPC1EIF4HCTDSP1 | |
| SCHEMBL3935737 | 0.91 | PABPC1 (0.41) | MEN1KMT2APABPC1EIF4HCTDSP1 | |
| SCHEMBL3935739 | 0.91 | PABPC1 (0.41) | MEN1KMT2APABPC1EIF4HCTDSP1 | |
| SCHEMBL3933441 | 0.91 | PABPC1 (0.34) | MEN1KMT2APABPC1EIF4HCTDSP1 | |
| SCHEMBL3933439 | 0.91 | PABPC1 (0.34) | MEN1KMT2APABPC1EIF4HCTDSP1 | |
| SCHEMBL3942685 | 0.89 | MEN1 (0.35) | MEN1KMT2AATMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1847250-B1 | Agents for colouring keratin fibres comprising zwitterionic azomethine dyes | PROCTER & GAMBLE (US) | 2009-12-23 | — | — | EP | claimed |
| US-7513918-B2 | Agents for coloring keratin fibers comprising zwitterionic azomethine dyes | THE PROCTER & GAMBLE COMPANY (US) | 2009-04-07 | — | — | US | claimed |
| EP-1852104-A1 | Agents for colouring keratin fibres comprising zwitterionic azomethine dyes | Wella Aktiengesellschaft (DE) | 2007-11-07 | — | — | EP | claimed |
| US-20070245501-A1 | Agents for coloring keratin fibers comprising zwitterionic azomethine dyes | WELLA OPERATIONS US, LLC | 2007-10-25 | — | — | US | claimed |
| EP-1847250-A1 | Agents for colouring keratin fibres comprising zwitterionic azomethine dyes | Wella Aktiengesellschaft (DE) | 2007-10-24 | — | — | EP | claimed |
| EP-1847250-B1 | Agents for colouring keratin fibres comprising zwitterionic azomethine dyes | PROCTER & GAMBLE (US) | 2009-12-23 | — | — | EP | disclosed |
| US-7513918-B2 | Agents for coloring keratin fibers comprising zwitterionic azomethine dyes | THE PROCTER & GAMBLE COMPANY (US) | 2009-04-07 | — | — | US | disclosed |
| EP-1852104-A1 | Agents for colouring keratin fibres comprising zwitterionic azomethine dyes | Wella Aktiengesellschaft (DE) | 2007-11-07 | — | — | EP | disclosed |
| WO-2007119228-A2 | AGENTS FOR COLOURING KERATIN FIBRES COMPRISING ZWITTERIONIC AZOMETHINE DYES | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-25 | — | — | WO | disclosed |
| US-20070245501-A1 | Agents for coloring keratin fibers comprising zwitterionic azomethine dyes | WELLA OPERATIONS US, LLC | 2007-10-25 | — | — | US | disclosed |
| EP-1847250-A1 | Agents for colouring keratin fibres comprising zwitterionic azomethine dyes | Wella Aktiengesellschaft (DE) | 2007-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070245501-A1 | Agents for coloring keratin fibers comprising zwitterionic azomethine dyes | KRT18, IK, RARG | MEN1 3437/4885KMT2A 385/4885ATM 3294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.